Related references
Note: Only part of the references are listed.Synergistic interaction of dietary cholesterol and dietary fat in inducing experimental steatohepatitis
Christopher Savard et al.
HEPATOLOGY (2013)
High Hepatic SCD1 Activity Is Associated with Low Liver Fat Content in Healthy Subjects under a Lipogenic Diet
Guenther Silbernagel et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2012)
Loss of FXR Protects against Diet-Induced Obesity and Accelerates Liver Carcinogenesis in ob/ob Mice
Yanqiao Zhang et al.
MOLECULAR ENDOCRINOLOGY (2012)
Internalization of Modified Lipids by CD36 and SR-A Leads to Hepatic Inflammation and Lysosomal Cholesterol Storage in Kupffer Cells
Veerle Bieghs et al.
PLOS ONE (2012)
The HIV Matrix Protein p17 Subverts Nuclear Receptors Expression and Induces a STAT1-Dependent Proinflammatory Phenotype in Monocytes
Barbara Renga et al.
PLOS ONE (2012)
Scavenger Receptor CD36 Expression Contributes to Adipose Tissue Inflammation and Cell Death in Diet-Induced Obesity
Lei Cai et al.
PLOS ONE (2012)
Activation of Pregnane X Receptor by Pregnenolone 16 α-carbonitrile Prevents High-Fat Diet-Induced Obesity in AKR/J Mice
Yongjie Ma et al.
PLOS ONE (2012)
Farnesoid X Receptor Deficiency Improves Glucose Homeostasis in Mouse Models of Obesity
Janne Prawitt et al.
DIABETES (2011)
Hepatic fatty acid translocase CD36 upregulation is associated with insulin resistance, hyperinsulinaemia and increased steatosis in non-alcoholic steatohepatitis and chronic hepatitis C
Maria Eugenia Miquilena-Colina et al.
GUT (2011)
Dietary cholesterol exacerbates hepatic steatosis and inflammation in obese LDL receptor-deficient mice
Savitha Subramanian et al.
JOURNAL OF LIPID RESEARCH (2011)
DNA microarrays to define and search for genes associated with obesity
Yunjung Kim et al.
BIOTECHNOLOGY JOURNAL (2010)
FXR activation reverses insulin resistance and lipid abnormalities and protects against liver steatosis in Zucker (fa/fa) obese rats
Sabrina Cipriani et al.
JOURNAL OF LIPID RESEARCH (2010)
Antiatherosclerotic effect of farnesoid X receptor
Andrea Mencarelli et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2009)
Farnesoid X receptor agonist WAY-362450 attenuates liver inflammation and fibrosis in murine model of non-alcoholic steatohepatitis
Songwen Zhang et al.
JOURNAL OF HEPATOLOGY (2009)
Hepatic fatty acid transporter Cd36 is a common target of LXR, PXR, and PPARγ in promoting steatosis
Jie Zhou et al.
GASTROENTEROLOGY (2008)
Dietary cholesterol, rather than liver steatosis, leads to hepatic inflammation in hyperlipidemic mouse models of nonalcoholic steatohepatitis
Kristiaan Wouters et al.
HEPATOLOGY (2008)
Increased hepatic CD36 expression contributes to dyslipidemia associated with diet-induced obesity
Debby P. Y. Koonen et al.
DIABETES (2007)
CD36-facilitated fatty acid uptake inhibits leptin production and signaling in adipose tissue
Tahar Hajri et al.
DIABETES (2007)
Nonalcoholic fatty liver disease: from pathogenesis to patient care
Gabriel Perlemuter et al.
NATURE CLINICAL PRACTICE ENDOCRINOLOGY & METABOLISM (2007)
FXR: a promising target for the metabolic syndrome?
Bertrand Cariou et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2007)
Disordered lipid metabolism and the pathogenesis of insulin resistance
David B. Savage et al.
PHYSIOLOGICAL REVIEWS (2007)
The farnesoid X receptor modulates adiposity and peripheral insulin sensitivity in mice
B Cariou et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Farnesoid X receptor is essential for normal glucose homeostasis
K Ma et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
Activation of the nuclear receptor FXR improves hyperglycemia and hyperlipidemia in diabetic mice
YQ Zhang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Bile acids reduce SR-BI expression in hepatocytes by a pathway involving FXR/RXR, SHP, and LRH-1
L Malerod et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2005)
The farnesoid X receptor modulates hepatic carbohydrate metabolism during the fasting-refeeding transition
D Duran-Sandoval et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Peroxisome proliferator-activated receptor-γ coactivator 1α (PGC-1α) regulates triglyceride metabolism by activation of the nuclear receptor FXR
YQ Zhang et al.
GENES & DEVELOPMENT (2004)
Enterohepatic circulation of bile salts in farnesoid x receptor-deficient mice - Efficient intestinal bile salt absorption in the absence of ileal bile acid-binding protein
T Kok et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Farnesoid X receptor agonists suppress hepatic apolipoprotein CIII expression
T Claudel et al.
GASTROENTEROLOGY (2003)
Definition of a novel growth factor-dependent signal cascade for the suppression of bile acid biosynthesis
JA Holt et al.
GENES & DEVELOPMENT (2003)
Natural structural variants of the nuclear receptor farnesoid X receptor affect transcriptional activation
YQ Zhang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Farnesoid X-activated receptor induces apolipoprotein C-II transcription: a molecular mechanism linking plasma triglyceride levels to bile acids
HR Kast et al.
MOLECULAR ENDOCRINOLOGY (2001)
Defective uptake and utilization of long chain fatty acids in muscle and adipose tissues of CD36 knockout mice
CT Coburn et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Targeted disruption of the nuclear receptor FXR/BAR impairs bile acid and lipid homeostasis
CJ Sinal et al.
CELL (2000)
Identification of a chemical tool for the orphan nuclear receptor FXR
PR Maloney et al.
JOURNAL OF MEDICINAL CHEMISTRY (2000)
Share Paper
